Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03107949 · ClinicalTrials.gov registry record · NA
Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing (RESCUE1)
A NA study, sponsored by Lungpacer Medical.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03107949: Completed NA study, sponsored by Lungpacer Medical.
NCT03107949 is a NA study that has completed, run by Lungpacer Medical. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03107949, a NA study, has completed, sponsored by Lungpacer Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
An early feasibility study to investigate the safety and feasibility of the Lungpacer Diaphragm Pacing Therapy System (DPTS) as a therapy to recondition and strengthen the diaphragm of patients who have been intubated and invasively mechanically ventilated for \> or = 7 days, have failed two or more spontaneous breathing trials (SBT), and were not hypervolemic during the latest SBT.
Primary Outcome
Successful placement of the LIVE Catheter via the Left Subclavian vein at the initiation of study will be assessed by placement confirmation via Chest Xray
Interventions
- DEVICE Lungpacer DPTS (Diaphragm Pacing Therapy System)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-06-20 |
| Est. Completion | 2018-02-18 |
| Phase | NA |
What the finished NCT03107949 record still lists
NCT03107949 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Lungpacer DPTS (Diaphragm Pacing Therapy System) is the first listed.
NCT03107949 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03107949 about?
NCT03107949 is a clinical study titled "Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing (RESCUE1)". An early feasibility study to investigate the safety and feasibility of the Lungpacer Diaphragm Pacing Therapy System (DPTS) as a therapy to recondition and strengthen the diaphragm of patients who have been intubated and invasively mechanically ventilated for \> or = 7 days, have failed two or more...
What is the current status of trial NCT03107949?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2017-06-20. Estimated completion is 2018-02-18.
What interventions are being tested in trial NCT03107949?
The interventions under investigation include: Lungpacer DPTS (Diaphragm Pacing Therapy System) (DEVICE).
Who is sponsoring clinical trial NCT03107949?
This trial is sponsored by Lungpacer Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03107949's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI